• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Laronde

life raft rescue safety buoy save drowning
Biotech

Flagship's Sail sends staff packing for 2nd time this year

The programmable RNA medicine outfit is laying off about 36 employees as the company sharpens its focus on immunology, a spokesperson said.
Darren Incorvaia Jul 18, 2025 12:55pm
Ship sailing through stormy seas

Flagship's Sail Biomedicines lays off 12 staffers

Apr 1, 2025 3:44pm
parachute chutes and ladders

Google DeepMind vet to join GSK—Chutes & Ladders

Oct 20, 2023 9:30am
sailboat ocean sea water boat ship

Flagship's embattled Laronde sets sail with Senda in merger

Oct 19, 2023 1:51pm
venture capital funding

Biotech's top 10 money raisers of 2021

Apr 18, 2022 3:00am
Diego Miralles MD CEO of Laronde and CEO-partner at Flagship Pioneering

Laronde banks $440M to ramp up next-gen RNA-based meds

Aug 30, 2021 6:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings